Label Design Affects Medication Safety in an Operating Room Crisis: A Controlled Simulation Study

Objective Several factors contribute to medication errors in clinical practice settings, including the design of medication labels. The objective of this study was to quantify the impact of label design on medication safety in a realistic, high-stress clinical situation. Methods Ninety-six anesthesia trainee participants were randomly assigned to either the redesigned or the current label condition. Participants were blinded to the study's focus on medication label design and their assigned label condition. Each participant was the sole anesthesia provider in a simulated operating room scenario involving an unexpected vascular injury. The surgeon asked the participant to administer hetastarch to the simulated patient because of hemodynamic instability. The fluid drawer of the anesthesia cart contained three 500-ml intravenous bags of hetastarch and one 500-ml intravenous bag of lidocaine. We hypothesized that redesigned labels would help participants correctly select hetastarch from the cart. If the participants incorrectly selected lidocaine from the cart, we hypothesized that the redesigned labels would help participants detect the lidocaine before administration. Results The percentage of participants who correctly selected hetastarch from the cart was significantly higher for the redesigned labels than the current labels (63% versus 40%; odds ratio, 2.61 [95% confidence interval, 1.1–6.1]; P = 0.03). Of the participants who incorrectly selected lidocaine from the cart, the percentage who detected the lidocaine before administration did not differ by label condition. Conclusions The redesigned labels helped participants correctly select hetastarch from the cart, thus preventing some potentially catastrophic medication errors from reaching the simulated patient.

[1]  R. Hughes Patient Safety and Quality: An Evidence-Based Handbook for Nurses , 2008 .

[2]  J W Kenagy,et al.  Naming, labeling, and packaging of pharmaceuticals. , 2001, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[3]  Edmond Israelski,et al.  Evaluation of Drug Label Designs Using Eye Tracking , 2005 .

[4]  Kevin Purdy,et al.  Drug name confusion: evaluating the effectiveness of capital ("Tall Man") letters using eye movement data. , 2004, Social science & medicine.

[5]  A. Hellebek,et al.  Identifying Facilitators and Barriers for Patient Safety in a Medicine Label Design System Using Patient Simulation and Interviews , 2016, Journal of patient safety.

[6]  Kevin Purdy,et al.  The Influence of Tall Man Lettering on Drug Name Confusion , 2010, Drug safety.

[7]  Kathryn Mearns,et al.  The Effect of Proximity, Tall Man Lettering, and Time Pressure on Accurate Visual Perception of Drug Names , 2013, Hum. Factors.

[8]  C. Burns,et al.  Using human factors methods to evaluate the labelling of injectable drugs. , 2008, Healthcare quarterly.

[9]  Alastair G. Gale,et al.  Labeling of Medicines and Patient Safety: Evaluating Methods of Reducing Drug Name Confusion , 2006, Hum. Factors.

[10]  J. Edworthy,et al.  Considering the impact of medicine label design characteristics on patient safety , 2006, Ergonomics.

[11]  R. Hughes,et al.  Medication Administration Safety , 2008 .

[12]  Kraig L. Schell,et al.  Using enhanced text to facilitate recognition of drug names: evidence from two experimental studies. , 2009, Applied ergonomics.